Intellia Therapeutics
The Associate Director, Pricing & Contracting at Intellia Therapeutics leads the development and execution of pricing, contracting, and market‑access strategies for the company’s CRISPR‑based therapies. This role supports launch readiness and post‑launch operations, collaborating with cross‑functional teams to create materials, manage contracts, and oversee revenue‑management and state price‑transparency reporting.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2014
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
1 week ago
Intellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory (NASDAQ:NTLA)
3 days ago
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Intellia Therapeutics.
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
2 weeks ago
Senior Director, Market Access Pricing & Contracting
NewAmsterdam Pharma
Global Head of Pricing & Innovative Contracting, EPD (m/f/d)
Abbott Laboratories
Strategy, Contracting & Pricing Lead
MoonLake Immunotherapeutics
Senior Director, US Pricing and Contracting
Invivyd
Senior Director, Pricing and Contracting
Mineralys Therapeutics
Senior Director, Pricing & Contracting
Zenas BioPharma